These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24656386)

  • 1. Comparative analysis of different oral approaches to treat Vibrio cholerae infection in adult mice.
    Jaiswal A; Koley H; Mitra S; Saha DR; Sarkar B
    Int J Med Microbiol; 2014 May; 304(3-4):422-30. PubMed ID: 24656386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of cocktail phage therapy in treating Vibrio cholerae infection in rabbit model.
    Jaiswal A; Koley H; Ghosh A; Palit A; Sarkar B
    Microbes Infect; 2013 Feb; 15(2):152-6. PubMed ID: 23159467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cocktail of three virulent bacteriophages prevents Vibrio cholerae infection in animal models.
    Yen M; Cairns LS; Camilli A
    Nat Commun; 2017 Feb; 8():14187. PubMed ID: 28146150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic potential of vibriophages against an experimental infection with Vibrio cholerae O1 in the RITARD model.
    Bhowmick TS; Koley H; Das M; Saha DR; Sarkar BL
    Int J Antimicrob Agents; 2009 Jun; 33(6):569-73. PubMed ID: 19157799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vibrio cholerae infection, novel drug targets and phage therapy.
    Fazil MH; Singh DV
    Future Microbiol; 2011 Oct; 6(10):1199-208. PubMed ID: 22004038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae 01 or 0139.
    Khan WA; Bennish ML; Seas C; Khan EH; Ronan A; Dhar U; Busch W; Salam MA
    Lancet; 1996 Aug; 348(9023):296-300. PubMed ID: 8709688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmission of Vibrio cholerae is antagonized by lytic phage and entry into the aquatic environment.
    Nelson EJ; Chowdhury A; Flynn J; Schild S; Bourassa L; Shao Y; LaRocque RC; Calderwood SB; Qadri F; Camilli A
    PLoS Pathog; 2008 Oct; 4(10):e1000187. PubMed ID: 18949027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose azithromycin for the treatment of cholera in adults.
    Saha D; Karim MM; Khan WA; Ahmed S; Salam MA; Bennish ML
    N Engl J Med; 2006 Jun; 354(23):2452-62. PubMed ID: 16760445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of phages to control Vibrio splendidus infection in the juvenile sea cucumber Apostichopus japonicus.
    Li Z; Li X; Zhang J; Wang X; Wang L; Cao Z; Xu Y
    Fish Shellfish Immunol; 2016 Jul; 54():302-11. PubMed ID: 27108378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model.
    Matsuda T; Freeman TA; Hilbert DW; Duff M; Fuortes M; Stapleton PP; Daly JM
    Surgery; 2005 Jun; 137(6):639-46. PubMed ID: 15933632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial, antisecretory and antihemorrhagic activity of Azadirachta indica used to treat cholera and diarrhea in India.
    Thakurta P; Bhowmik P; Mukherjee S; Hajra TK; Patra A; Bag PK
    J Ethnopharmacol; 2007 May; 111(3):607-12. PubMed ID: 17314018
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Chaudhary N; Mohan B; Kaur H; Modgil V; Kant V; Bhatia A; Taneja N
    Antibiotics (Basel); 2023 Jun; 12(6):. PubMed ID: 37370365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the role of bacteriophage in the control of cholera outbreaks.
    Jensen MA; Faruque SM; Mekalanos JJ; Levin BR
    Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4652-7. PubMed ID: 16537404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rice-ORS versus glucose-ORS in management of severe cholera due to Vibrio cholerae O139 Bengal: a randomized, controlled clinical trial.
    Hossain MS; Salam MA; Rabbani GH; Kabir I; Biswas R; Mahalanabis D
    J Health Popul Nutr; 2003 Dec; 21(4):325-31. PubMed ID: 15038587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First do no harm: making oral rehydration solution safer in a cholera epidemic.
    Daniels NA; Simons SL; Rodrigues A; Gunnlaugsson G; Forster TS; Wells JG; Hutwagner L; Tauxe RV; Mintz ED
    Am J Trop Med Hyg; 1999 Jun; 60(6):1051-5. PubMed ID: 10403342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominant
    Hays SG; Seed KD
    Elife; 2020 Apr; 9():. PubMed ID: 32329714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological activity & interaction of Vibrio cholerae bacteriophages in rabbit ileal loop.
    Sarkar BL; Chakrabarti AK; Koley H; Chakrabarti MK; De SP
    Indian J Med Res; 1996 Jul; 104():139-41. PubMed ID: 8783517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reviving Phage Therapy for the Treatment of Cholera.
    Bhandare S; Colom J; Baig A; Ritchie JM; Bukhari H; Shah MA; Sarkar BL; Su J; Wren B; Barrow P; Atterbury RJ
    J Infect Dis; 2019 Feb; 219(5):786-794. PubMed ID: 30395214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetracycline in the treatment of severe cholera due to Vibrio cholerae O139 Bengal.
    Hossain MS; Salam MA; Rabbani GH; Kabir I; Biswas R; Mahalanabis D
    J Health Popul Nutr; 2002 Mar; 20(1):18-25. PubMed ID: 12022154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of the evolutionary arms race between Vibrio cholerae and Vibriophage clinical isolates.
    Yen M; Camilli A
    Int Microbiol; 2017 Sep; 20(3):116-120. PubMed ID: 29446802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.